Most information on the dose-response of radiation-induced cancer is derived from data on the A-bomb survivors who were exposed to γ-rays and neutrons. Since, for radiation protection purposes, the dose span of main interest is between 0 and 1Gy, the analysis of the A-bomb survivors is usually focused on this range. However, estimates of cancer risk for doses above 1Gy are becoming more important for radiotherapy patients and for long-term manned missions in space research. Therefore in this work, emphasis is placed on doses relevant for radiotherapy with respect to radiation-induced solid cancer. The analysis of the A-bomb survivor's data was extended by including two extra high-dose categories (4-6Sv and 6-13Sv) and by an attempted combin...
Background. - Female breast cancer is the most frequent cancer, both in incidence and mortality. It ...
In developed countries, more than half of all cancer patients receive radiotherapy at some stage in ...
Currently, most analyses of the A-bomb survivors' solid tumour and leukaemia data are based on a...
Most information on the dose-response of radiation-induced cancer is derived from data on the A-bomb...
Purpose: Development of a model characterizing risk variation with RBE to investigate how the incide...
The new radiation dose estimates for Hiroshima and Nagasaki are here combined with epidemiologic dat...
PURPOSE: Development of a model characterizing risk variation with RBE to investigate how the incide...
Since 1950 about 87 000 A-bomb survivors from Hiroshima and Nagasaki have been monitored within the ...
<p><i>Reprinted with permission from figure 3 of “Studies of the mortality of atomic bomb survivors<...
A previous investigation has uncoupled the solid cancer risk coefficient for neutrons from the low d...
A recent update on the atomic bomb survivor cancer mortality data has concluded that excess relative...
The dose-response relationship for radiation-induced leu-kemia was examined in a pooled analysis of ...
Exposure of human body to neutrons occurs in radiotherapy using high-energy radiations. This review ...
Even today when nearly 80 years have passed after the atomic bomb (A-bomb) was dropped, there are st...
A recent update on the atomic bomb survivor cancer mortality data has concluded that excess relative...
Background. - Female breast cancer is the most frequent cancer, both in incidence and mortality. It ...
In developed countries, more than half of all cancer patients receive radiotherapy at some stage in ...
Currently, most analyses of the A-bomb survivors' solid tumour and leukaemia data are based on a...
Most information on the dose-response of radiation-induced cancer is derived from data on the A-bomb...
Purpose: Development of a model characterizing risk variation with RBE to investigate how the incide...
The new radiation dose estimates for Hiroshima and Nagasaki are here combined with epidemiologic dat...
PURPOSE: Development of a model characterizing risk variation with RBE to investigate how the incide...
Since 1950 about 87 000 A-bomb survivors from Hiroshima and Nagasaki have been monitored within the ...
<p><i>Reprinted with permission from figure 3 of “Studies of the mortality of atomic bomb survivors<...
A previous investigation has uncoupled the solid cancer risk coefficient for neutrons from the low d...
A recent update on the atomic bomb survivor cancer mortality data has concluded that excess relative...
The dose-response relationship for radiation-induced leu-kemia was examined in a pooled analysis of ...
Exposure of human body to neutrons occurs in radiotherapy using high-energy radiations. This review ...
Even today when nearly 80 years have passed after the atomic bomb (A-bomb) was dropped, there are st...
A recent update on the atomic bomb survivor cancer mortality data has concluded that excess relative...
Background. - Female breast cancer is the most frequent cancer, both in incidence and mortality. It ...
In developed countries, more than half of all cancer patients receive radiotherapy at some stage in ...
Currently, most analyses of the A-bomb survivors' solid tumour and leukaemia data are based on a...